Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
CHGB,Secretogranin-1,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.27 [1.19-1.37],7.85926267376524e-12,trans
CHGB,Secretogranin-1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,0.66 [0.53-0.84],0.00051894519982924,trans
CHGB,Secretogranin-1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1.07 [1.03-1.11],0.00074294360629888,trans
CHGB,Secretogranin-1,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,1.08 [1.02-1.15],0.00782002259535903,trans
CHGB,Secretogranin-1,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,1.06 [1.02-1.11],0.00787580671452858,trans
CHGB,Secretogranin-1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,1.09 [1.02-1.15],0.00850053646544553,trans
CHGB,Secretogranin-1,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,13,1.06 [1.02-1.12],0.00929257276441787,trans
CHGB,Secretogranin-1,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,0.85 [0.69-1.05],0.125443089074019,trans
CHGB,Secretogranin-1,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.8 [0.61-1.06],0.126379907924607,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Wald ratio,1,0.96 [0.92-1.01],0.13861099052844,trans
CHGB,Secretogranin-1,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.09 [0.97-1.23],0.166057643165127,trans
CHGB,Secretogranin-1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.86 [0.69-1.07],0.169395970719755,trans
CHGB,Secretogranin-1,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,0.93 [0.84-1.04],0.185703320244904,trans
CHGB,Secretogranin-1,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,0.86 [0.69-1.08],0.190123683389877,trans
CHGB,Secretogranin-1,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,7,1.06 [0.97-1.17],0.190335148939319,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,0.98 [0.95-1.01],0.206202229511452,trans
CHGB,Secretogranin-1,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,0.92 [0.8-1.05],0.231710583153814,trans
CHGB,Secretogranin-1,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,4,0.98 [0.96-1.01],0.245593371187473,trans
CHGB,Secretogranin-1,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.93 [0.82-1.06],0.267468259526419,trans
CHGB,Secretogranin-1,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.95 [0.84-1.06],0.357779165665455,trans
CHGB,Secretogranin-1,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.95 [0.84-1.07],0.363834272051993,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Wald ratio,1,0.96 [0.87-1.06],0.394512381547616,trans
CHGB,Secretogranin-1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,8,1.01 [0.98-1.04],0.421491740230343,trans
CHGB,Secretogranin-1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,1.03 [0.96-1.09],0.425392373682075,trans
CHGB,Secretogranin-1,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,0.92 [0.76-1.12],0.425459174709438,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,0.99 [0.96-1.02],0.460151523041404,trans
CHGB,Secretogranin-1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,0.99 [0.97-1.02],0.566604013501584,trans
CHGB,Secretogranin-1,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.01 [0.97-1.06],0.568414665339134,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,0.98 [0.91-1.06],0.588398410668733,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,5,0.99 [0.96-1.03],0.631837249680138,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,0.99 [0.96-1.03],0.650162343268639,trans
CHGB,Secretogranin-1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,14,0.99 [0.96-1.02],0.650281085932212,trans
CHGB,Secretogranin-1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.94 [0.7-1.26],0.659109436660742,trans
CHGB,Secretogranin-1,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,35,1.01 [0.97-1.04],0.665683465597251,trans
CHGB,Secretogranin-1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,1.01 [0.95-1.09],0.667205597496391,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,5,0.99 [0.95-1.03],0.704195843409313,trans
CHGB,Secretogranin-1,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,0.98 [0.87-1.1],0.707274590209824,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.03 [0.89-1.18],0.72535873404396,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,1.02 [0.92-1.12],0.72535873404396,trans
CHGB,Secretogranin-1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,0.97 [0.82-1.15],0.732880736237656,trans
CHGB,Secretogranin-1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,1.05 [0.79-1.4],0.746339968506004,trans
CHGB,Secretogranin-1,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,0.97 [0.8-1.18],0.763992047124575,trans
CHGB,Secretogranin-1,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,1.02 [0.91-1.13],0.765762073065661,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,15,1 [0.99-1.01],0.779821924206176,trans
CHGB,Secretogranin-1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,0.99 [0.9-1.09],0.804524636555907,trans
CHGB,Secretogranin-1,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,0.98 [0.82-1.18],0.832966773674205,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Wald ratio,1,1 [0.95-1.05],0.849402053335634,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Wald ratio,1,1 [0.95-1.05],0.855760033470218,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,1.02 [0.79-1.31],0.885587659716312,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,10,1 [0.97-1.04],0.901753900789106,trans
CHGB,Secretogranin-1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,0.99 [0.81-1.21],0.907602396729953,trans
CHGB,Secretogranin-1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,10,1 [0.96-1.04],0.946882617189358,trans
CHGB,Secretogranin-1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1 [0.97-1.04],0.97743006205804,trans
CHGB,Secretogranin-1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,9,1 [0.94-1.07],0.982610404520423,trans
CHGB,Secretogranin-1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,3,1 [0.88-1.13],0.987498298542823,trans
CHGB,Secretogranin-1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,1 [0.87-1.15],0.992743785329324,trans
CHGB,Secretogranin-1,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,7,1 [0.96-1.05],0.999722535429792,trans
